Foreign direct investments in South Korea hit a record high in 2024, driven by Chinese and Japanese investors in the manufacturing sector, the Ministry of Trade, Industry and Energy said on Tuesday.

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical trials. The company said it is using organoids – small ...

South Korea’s largest institutional investor, the National Pension Service (NPS), remains a strong backer of the country’s ...

Global private equity firm KKR & Co. Inc., formerly known as Kohlberg Kravis Roberts & Co., has sold a 9.5% stake in HD Hyundai Marine Solution Co. in ...

Hyundai Motor Group has created a future business strategy division that serves as a control tower for the automotive group’s expansion into new areas through mergers and acquisitions and startup ...

SK Earthon Co., the petroleum exploration and production (E&P) unit of South Korea’s top energy company SK Innovation Co., has secured rights to deve ...

The head of Morgan Stanley’s Seoul office is stepping down after overseeing a series of landmark deals over more than a ...

Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufacturing orga ...

The head of The Carlyle Group met with Korean retail investors in a rare session on Thursday, sharing insights on the US ...

South Korean institutional investors are increasingly interested in separately managed accounts (SMAs) that offer customized strategies, as well as exploring n ...

Mirae Asset Global Investments Co. now manages more than 400 trillion won ($288 billion) in assets for the first time since its first global venture over two d ...

Kia Corp. will release a new purpose-built vehicle (PBV) model every two years, with plans to launch the PV9 in 2029 and its first model, the PV5, this year to drive future growth with PBVs alongside ...